# Study in Adults With Severe Chronic Rhinosinusitis With Nasal Polyposis Treated With Dupilumab in France

> **NCT06393946** · — · ACTIVE_NOT_RECRUITING · sponsor: **Sanofi** · enrollment: 150 (estimated)

## Conditions studied

- Chronic Rhinosinusitis With Nasal Polyposis

## Interventions

- **DRUG:** Dupilumab

## Key facts

- **NCT ID:** NCT06393946
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-10-20
- **Primary completion:** 2026-04-28
- **Final completion:** 2026-07-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-12-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06393946

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06393946, "Study in Adults With Severe Chronic Rhinosinusitis With Nasal Polyposis Treated With Dupilumab in France". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06393946. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*